Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Pennsylvania State Univ Hershey Med Ctr
Hershey, Pennsylvania
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 101
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| John W. Kitchens | Conflict of Interest | Genentech | $500,000 - $549,999 | 2015 |
| William Wood | Conflict of Interest | Genentech | $500,000 - $549,999 | 2015 |
| Thomas Stone | Conflict of Interest | Genentech | $500,000 - $549,999 | 2015 |
| Ricky D. Isernhagen | Conflict of Interest | Genentech | $500,000 - $549,999 | 2015 |
| Calvin Mein | Conflict of Interest | Regeneron Pharmaceuticals | $150,000 - $199,999 | 2015 |
| Philip Ferrone | Conflict of Interest | Regeneron Pharmaceuticals | $100,000 - $149,999 | 2014 |
| Vincent Deramo | Conflict of Interest | Regeneron Pharmaceuticals | $100,000 - $149,999 | 2014 |
| Jeffrey Heier | Conflict of Interest | Bayer | $60,000 - $79,999 | 2014 |
| James Adair | Conflict of Interest | Keystone Nano, Inc. | $60,000 - $79,999 | 2013 |
| Lawrence Singerman | Conflict of Interest | Regeneron Pharmaceuticals | $40,000 - $59,999 | 2015 |
| Charles Wykoff | Conflict of Interest | Bayer | $40,000 - $59,999 | 2018 |
| Philip Ferrone | Conflict of Interest | F. Hoffman-La Roche Ltd. | $40,000 - $59,999 | 2014 |
| Steven Lin | Conflict of Interest | Genentech | $40,000 - $59,999 | 2019 |
| Clement Chan | Conflict of Interest | Genentech | $40,000 - $59,999 | 2019 |
| David Fastenberg | Conflict of Interest | Regeneron Pharmaceuticals | $40,000 - $59,999 | 2014 |
| Rahul Khurana | Conflict of Interest | Genentech | $20,000 - $39,999 | 2014 |
| William W. Busse | Conflict of Interest | Novartis | $20,000 - $39,999 | 2013 |
| Thomas W. Stone | Conflict of Interest | Regeneron Pharmaceuticals | $20,000 - $39,999 | 2015 |
| David Brown | Conflict of Interest | Bayer | $20,000 - $39,999 | 2014 |
| Raj Maturi | Conflict of Interest | Allergan, Inc | $20,000 - $39,999 | 2014 |
| Wayne Solley | Conflict of Interest | Regeneron Pharmaceuticals | $20,000 - $39,999 | 2014 |
| David Callanan | Conflict of Interest | Allergan, Inc | $20,000 - $39,999 | 2014 |
| Howard Fine | Conflict of Interest | Allergan, Inc. | $10,000 - $19,999 | 2015 |
| Rahul Khurana | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Howard Fine | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| Gaurav Shah | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Michael Singer | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Michael Singer | Conflict of Interest | Allergan, Inc | $10,000 - $19,999 | 2014 |
| Gaurav Shah | Conflict of Interest | Allergan, Inc. | $10,000 - $19,999 | 2014 |
| Joseph Coney | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| John Wells | Conflict of Interest | Genentech | $10,000 - $19,999 | 2017 |
| Howard Fine | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Rahul Khurana | Conflict of Interest | Genentech | $10,000 - $19,999 | 2019 |
| Steven Lin | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| Brian Connolly | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| Rahul Khurana | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2019 |
| Clement Chan | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| Joseph Coney | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| W Lloyd Clark | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| Sumit Shah | Conflict of Interest | Genentech | $10,000 - $19,999 | 2017 |
| W Lloyd Clark | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Philip Ferrone | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| William W. Busse | Conflict of Interest | Merck | $10,000 - $19,999 | 2015 |
| John W. Kitchens | Conflict of Interest | Bayer | $10,000 - $19,999 | 2017 |
| David Brown | Conflict of Interest | Bayer | $10,000 - $19,999 | 2014 |
| Byron S. Ladd | Conflict of Interest | Genentech | $10,000 - $19,999 | 2014 |
| Dennis Marcus | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Joseph Coney | Conflict of Interest | Allergan, Inc | $10,000 - $19,999 | 2014 |
| Jeffrey Heier | Conflict of Interest | Regeneron Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Jeffrey Heier | Conflict of Interest | Allergan, Inc | $10,000 - $19,999 | 2014 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.